{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:32:39Z","timestamp":1762432359608,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-023-00815-5","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T07:01:47Z","timestamp":1693897307000},"page":"145-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A successful treatment for chronic active Epstein-Barr virus disease with Nephrotic Syndrome"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9411-4786","authenticated-orcid":false,"given":"Yasuhiro","family":"Inaba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Miyazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Imadome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Aratake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"issue":"8377","key":"815_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s0140-6736(84)90994-2","volume":"1","author":"TE Starzl","year":"1984","unstructured":"Starzl TE, Porter KA, Iwatsuki S, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet. 1984;1(8377):583\u20137. https:\/\/doi.org\/10.1016\/s0140-6736(84)90994-2.","journal-title":"Lancet"},{"issue":"4","key":"815_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1086\/367988","volume":"187","author":"H Kimura","year":"2003","unstructured":"Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis. 2003;187(4):527\u201333. https:\/\/doi.org\/10.1086\/367988.","journal-title":"J Infect Dis"},{"issue":"9","key":"815_CR3","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","volume":"20","author":"JI Cohen","year":"2009","unstructured":"Cohen JI, Kimura H, Nakamura S, et al. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8\u20139 September 2008. Ann Oncol. 2009;20(9):1472\u201382. https:\/\/doi.org\/10.1093\/annonc\/mdp064.","journal-title":"Ann Oncol"},{"issue":"22","key":"815_CR4","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","volume":"117","author":"JI Cohen","year":"2011","unstructured":"Cohen JI, Jaffe ES, Dale JK, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011;117(22):5835\u201349. https:\/\/doi.org\/10.1182\/blood-2010-11-316745.","journal-title":"Blood"},{"issue":"2","key":"815_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"J-I Henter","year":"2007","unstructured":"Henter J-I, Horne A, Aric\u00f3 M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331. https:\/\/doi.org\/10.1002\/pbc.21039.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"815_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/bmt.2010.122","volume":"46","author":"K Kawa","year":"2011","unstructured":"Kawa K, Sawada A, Sato M, et al. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transplant. 2011;46(1):77\u201383. https:\/\/doi.org\/10.1038\/bmt.2010.122.","journal-title":"Bone Marrow Transplant"},{"issue":"9225","key":"815_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0140-6736(00)02488-0","volume":"356","author":"T Okamura","year":"2000","unstructured":"Okamura T, Hatsukawa Y, Arai H, et al. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation. Lancet. 2000;356(9225):223\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(00)02488-0.","journal-title":"Lancet"},{"issue":"9","key":"815_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ajh.21247","volume":"83","author":"E Sato","year":"2008","unstructured":"Sato E, Ohga S, Kuroda H, et al. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disease in Japan. Am J Hematol. 2008;83(9):721\u20137. https:\/\/doi.org\/10.1002\/ajh.21247.","journal-title":"Am J Hematol"},{"issue":"10","key":"815_CR9","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1086\/587671","volume":"46","author":"K Gotoh","year":"2008","unstructured":"Gotoh K, Ito Y, Shibata-Watanabe Y, et al. Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. Clin Infect Dis. 2008;46(10):1525\u201334. https:\/\/doi.org\/10.1086\/587671.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"815_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/blood.v98.2.280","volume":"98","author":"H Kimura","year":"2001","unstructured":"Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001;98(2):280\u20136. https:\/\/doi.org\/10.1182\/blood.v98.2.280.","journal-title":"Blood"},{"issue":"8525","key":"815_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/s0140-6736(87)91980-5","volume":"1","author":"K Kawa-Ha","year":"1987","unstructured":"Kawa-Ha K, Franco E, Doi S, et al. Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2. Lancet. 1987;1(8525):154. https:\/\/doi.org\/10.1016\/s0140-6736(87)91980-5.","journal-title":"Lancet"},{"issue":"3","key":"815_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, et al. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673\u201386. https:\/\/doi.org\/10.1182\/blood-2011-10-381921.","journal-title":"Blood"},{"issue":"2","key":"815_CR13","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1182\/blood.V72.2.520.520","volume":"72","author":"MM Zutter","year":"1988","unstructured":"Zutter MM, Martin PJ, Sale GE, et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood. 1988;72(2):520\u20139. https:\/\/doi.org\/10.1182\/blood.V72.2.520.520.","journal-title":"Blood"},{"issue":"1","key":"815_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.humpath.2011.02.024","volume":"43","author":"MR Steciuk","year":"2012","unstructured":"Steciuk MR, Massengill S, Banks PM. In immunocompromised patients, Epstein-Barr virus lymphadenitis can mimic angioimmunoblastic T-cell lymphoma morphologically, immunophenotypically, and genetically: a case report and review of the literature. Human Pathol. 2012;43(1):127\u201333. https:\/\/doi.org\/10.1016\/j.humpath.2011.02.024.","journal-title":"Human Pathol"},{"issue":"1","key":"815_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.prp.2009.03.005","volume":"206","author":"K Hatanaka","year":"2010","unstructured":"Hatanaka K, Nakamura N, Kojima M, et al. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma. Pathol Res Pract. 2010;206(1):9\u201313. https:\/\/doi.org\/10.1016\/j.prp.2009.03.005.","journal-title":"Pathol Res Pract"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-023-00815-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-023-00815-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-023-00815-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:04:36Z","timestamp":1717232676000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-023-00815-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1007\/s13730-023-00815-5","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"9 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have declared no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal participants"}}]}}